Page last updated: 2024-10-25

ciglitazone and Leukemia, Promyelocytic, Acute

ciglitazone has been researched along with Leukemia, Promyelocytic, Acute in 1 studies

ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.

Leukemia, Promyelocytic, Acute: An acute myeloid leukemia in which abnormal PROMYELOCYTES predominate. It is frequently associated with DISSEMINATED INTRAVASCULAR COAGULATION.

Research Excerpts

ExcerptRelevanceReference
"In the present study we investigated the in vitro apoptosis inducing effects of peroxisome proliferator-activated receptor-gamma (PPAR-gamma) ligand ciglitazone (CGZ) on acute promyelocytic leukemia (APL) NB4 cells and its mechanisms of action."3.75Activation of peroxisome proliferator-activated receptor-gamma induces apoptosis on acute promyelocytic leukemia cells via downregulation of XIAP. ( Fang, ZG; Guo, YW; He, Y; Huang, RW; Li, XD; Lin, DJ; Liu, JJ; Liu, PQ; Si, XN; Wang, CZ; Wu, XY; Xiao, RZ; Xu, Y, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, JJ1
Guo, YW1
Fang, ZG1
Si, XN1
Wu, XY1
Liu, PQ1
Lin, DJ1
Xiao, RZ1
Xu, Y1
Wang, CZ1
Li, XD1
He, Y1
Huang, RW1

Other Studies

1 other study available for ciglitazone and Leukemia, Promyelocytic, Acute

ArticleYear
Activation of peroxisome proliferator-activated receptor-gamma induces apoptosis on acute promyelocytic leukemia cells via downregulation of XIAP.
    International journal of molecular medicine, 2009, Volume: 24, Issue:5

    Topics: Anilides; Aniline Compounds; Apoptosis; Blotting, Western; Caspase 3; Cell Line, Tumor; Cell Prolife

2009